These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 28743407)
1. Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications. Lange S; Pluchino N; Fehlmann A; Marci R; Boukrid M; Jazia IB; Petignat P; Dubuisson J Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():239-244. PubMed ID: 28743407 [TBL] [Abstract][Full Text] [Related]
2. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women. Lieng M; Berner E; Busund B J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521 [TBL] [Abstract][Full Text] [Related]
3. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation. Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205 [TBL] [Abstract][Full Text] [Related]
4. Incidence of Leiomyosarcoma at Surgery for Presumed Uterine Myomas in Different Age Groups. Rey Valzacchi GM; Rosas P; Uzal M; Gil SJ; Viglierchio VT J Minim Invasive Gynecol; 2020; 27(4):926-929. PubMed ID: 31260748 [TBL] [Abstract][Full Text] [Related]
5. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience. Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821 [TBL] [Abstract][Full Text] [Related]
6. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study. Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020 [TBL] [Abstract][Full Text] [Related]
8. [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?]. Leung F; Terzibachian JJ; Gay C; Chung Fat B; Aouar Z; Lassabe C; Maillet R; Riethmuller D Gynecol Obstet Fertil; 2009 Feb; 37(2):109-14. PubMed ID: 19200764 [TBL] [Abstract][Full Text] [Related]
9. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study. Skorstad M; Kent A; Lieng M Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683 [TBL] [Abstract][Full Text] [Related]
10. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas. Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of occult uterine leiomyosarcomas. Beyan E; Kanmaz AG; İnan AH; Karataşlı V; Tutar SO; Alan M; Töz E; Sancı M Ginekol Pol; 2019; 90(8):433-437. PubMed ID: 31482545 [TBL] [Abstract][Full Text] [Related]
12. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat? Mettler L; Abdusattarova K; Alkatout I Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085 [TBL] [Abstract][Full Text] [Related]
13. Comparison of 30-day Complication Rates between Laparoscopic Myomectomy and Total Laparoscopic Hysterectomy for the Treatment of Uterine Leiomyoma in Women Older Than Age 40. Sheyn D; Bretschnieder CE; Mahajan ST; El-Nashar S; Billow M; Ninivaggio CS J Minim Invasive Gynecol; 2019; 26(6):1076-1082. PubMed ID: 30385429 [TBL] [Abstract][Full Text] [Related]
14. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment? DeMulder D; Ascher SM AJR Am J Roentgenol; 2018 Dec; 211(6):1405-1415. PubMed ID: 30354268 [TBL] [Abstract][Full Text] [Related]
15. Incidence of occult uterine sarcoma and other unexpected pathologies in patients having surgery for presumed myomas: A retrospective observational study. Mühlenbrock MV; Navarrete-Rey P; Kovoor E; Guzman-Rojas R; Troncoso F; Miranda-Mendoza I J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):101992. PubMed ID: 33217603 [TBL] [Abstract][Full Text] [Related]
16. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women. Parker W; Pritts E; Olive D J Minim Invasive Gynecol; 2015; 22(4):696-7. PubMed ID: 25623370 [No Abstract] [Full Text] [Related]
17. Survey among ESGE members on leiomyosarcoma morcellation incidence. Tanos V; Brölmann H; DeWilde RL; O'Donovan P; Symeonidou E; Campo R Gynecol Surg; 2017; 14(1):25. PubMed ID: 29238287 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women. Pados G; Tsolakidis D; Theodoulidis V; Makedos A; Zaramboukas T; Tarlatzis B Hum Reprod; 2017 Oct; 32(10):2036-2041. PubMed ID: 28938732 [TBL] [Abstract][Full Text] [Related]
19. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas. Ludwin A; Gawron I; Pityński K Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842 [TBL] [Abstract][Full Text] [Related]
20. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids? Parker WH; Pritts EA; Olive DL Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]